Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the medical research company’s stock. Several other brokerages also recently weighed in on CTSO. D. Boral Capital reiterated a “buy” rating and issued a $10.00 price […]
Stock analysts at StockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the medical research company’s stock. Several other brokerages also recently weighed in on CTSO. D. Boral Capital reiterated a “buy” rating and issued a $10.00 price […]
